Supramolecular hydrogelators and hydrogels: from soft matter to molecular biomaterials

X Du, J Zhou, J Shi, B Xu - Chemical reviews, 2015 - ACS Publications
In this review we intend to provide a relatively comprehensive summary of the work of
supramolecular hydrogelators after 2004 and to put emphasis particularly on the …

The promise and challenges of immune agonist antibody development in cancer

PA Mayes, KW Hance, A Hoos - Nature Reviews Drug Discovery, 2018 - nature.com
Immune cell functions are regulated by co-inhibitory and co-stimulatory receptors. The first
two generations of cancer immunotherapy agents consist primarily of antagonist antibodies …

An aggregation advisor for ligand discovery

JJ Irwin, D Duan, H Torosyan, AK Doak… - Journal of medicinal …, 2015 - ACS Publications
Colloidal aggregation of organic molecules is the dominant mechanism for artifactual
inhibition of proteins, and controls against it are widely deployed. Notwithstanding an …

Can invalid bioactives undermine natural product-based drug discovery?

J Bisson, JB McAlpine, JB Friesen… - Journal of medicinal …, 2016 - ACS Publications
High-throughput biology has contributed a wealth of data on chemicals, including natural
products (NPs). Recently, attention was drawn to certain, predominantly synthetic …

Enzyme-instructed self-assembly: a multistep process for potential cancer therapy

J Zhou, B Xu - Bioconjugate chemistry, 2015 - ACS Publications
The central dogma of the action of current anticancer drugs is that the drug tightly binds to its
molecular target for inhibition. The reliance on tight ligand–receptor binding, however, is …

Targeting the bacterial division protein FtsZ

KA Hurley, TMA Santos, GM Nepomuceno… - Journal of medicinal …, 2016 - ACS Publications
Similar to its eukaryotic counterpart, the prokaryotic cytoskeleton is essential for the
structural and mechanical properties of bacterial cells. The essential protein FtsZ is a central …

Revisiting the structure of arabinogalactan from Lycium barbarum and the impact of its side chain on anti-ageing activity

W Huang, M Zhao, X Wang, Y Tian, C Wang, J Sun… - Carbohydrate …, 2022 - Elsevier
In this study, we obtained all the homogeneous LBGP70 (arabinogalactan-protein complex),
LBGP70-OL (sugar chain of LBGP70), and LBGP70-OL-I (backbone part of LBGP70-OL) …

Colloidal aggregation: From screening nuisance to formulation nuance

AN Ganesh, EN Donders, BK Shoichet, MS Shoichet - Nano Today, 2018 - Elsevier
It is well known that small molecule colloidal aggregation is a leading cause of false
positives in early drug discovery. Colloid-formers are diverse and well represented among …

[HTML][HTML] Nuisance compounds in cellular assays

JL Dahlin, DS Auld, I Rothenaigner, S Haney… - Cell chemical …, 2021 - cell.com
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity ("
nuisance compounds") are routinely encountered in cellular assays, including phenotypic …

Demonstrating in-cell target engagement using a pirin protein degradation probe (CCT367766)

NEA Chessum, SY Sharp, JJ Caldwell… - Journal of medicinal …, 2018 - ACS Publications
Demonstrating intracellular protein target engagement is an essential step in the
development and progression of new chemical probes and potential small molecule …